| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial
|
Tristram, Amanda
|
|
2014
|
15 |
12 |
p. 1361-1368
8 p.
|
artikel
|
| 2 |
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
|
Noh, Sung Hoon
|
|
2014
|
15 |
12 |
p. 1389-1396
8 p.
|
artikel
|
| 3 |
Antibody–drug conjugate for advanced melanoma?
|
Sharma, Sharan Prakash
|
|
2014
|
15 |
12 |
p. e534-
1 p.
|
artikel
|
| 4 |
Assessment and approval of drugs to be reviewed in the UK
|
Geddes, Linda
|
|
2014
|
15 |
12 |
p. e530-
1 p.
|
artikel
|
| 5 |
Cancer Hair
|
Begum, Fatiha
|
|
2014
|
15 |
12 |
p. 1302-
1 p.
|
artikel
|
| 6 |
Correction to Lancet Oncol 2014; 15: 1263
|
|
|
2014
|
15 |
12 |
p. e528-
1 p.
|
artikel
|
| 7 |
Correction to Lancet Oncol 2014; 15: 1189
|
|
|
2014
|
15 |
12 |
p. e528-
1 p.
|
artikel
|
| 8 |
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial
|
Ellis, Peter M
|
|
2014
|
15 |
12 |
p. 1379-1388
10 p.
|
artikel
|
| 9 |
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial
|
Ramalingam, Suresh S
|
|
2014
|
15 |
12 |
p. 1369-1378
10 p.
|
artikel
|
| 10 |
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers
|
Horeweg, Nanda
|
|
2014
|
15 |
12 |
p. 1342-1350
9 p.
|
artikel
|
| 11 |
Earlier cancer diagnosis would reduce NHS costs
|
Wilkinson, Emma
|
|
2014
|
15 |
12 |
p. e529-
1 p.
|
artikel
|
| 12 |
Effect of docetaxel on safety and efficacy of radium-223
|
Den, Robert B
|
|
2014
|
15 |
12 |
p. 1292-1293
2 p.
|
artikel
|
| 13 |
Effect of HIV infection on the outcome of cancer therapy in children
|
Stefan, Daniela C
|
|
2014
|
15 |
12 |
p. e562-e567
nvt p.
|
artikel
|
| 14 |
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial
|
Hoskin, Peter
|
|
2014
|
15 |
12 |
p. 1397-1406
10 p.
|
artikel
|
| 15 |
ESMO 2014 Congress
|
Coburn, Cassandra
|
|
2014
|
15 |
12 |
p. 1297-1298
2 p.
|
artikel
|
| 16 |
European euthanasia laws: questions of compassion
|
Mohammadi, Dara
|
|
2014
|
15 |
12 |
p. 1294-1295
2 p.
|
artikel
|
| 17 |
France announces tobacco legislation plan
|
Burki, Talha Khan
|
|
2014
|
15 |
12 |
p. e532-
1 p.
|
artikel
|
| 18 |
Global burden of human papillomavirus-positive head and neck cancers
|
Chaturvedi, Anil K
|
|
2014
|
15 |
12 |
p. 1282-1283
2 p.
|
artikel
|
| 19 |
Guanylin hormone loss could trigger colon cancer
|
Tanday, Sanjay
|
|
2014
|
15 |
12 |
p. e537-
1 p.
|
artikel
|
| 20 |
How do the AMAROS trial results change practice?
|
Boughey, Judy C
|
|
2014
|
15 |
12 |
p. 1280-1281
2 p.
|
artikel
|
| 21 |
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
|
Ndiaye, Cathy
|
|
2014
|
15 |
12 |
p. 1319-1331
13 p.
|
artikel
|
| 22 |
Improving prognosis after surgery for gastric cancer
|
Nishida, Toshirou
|
|
2014
|
15 |
12 |
p. 1290-1292
3 p.
|
artikel
|
| 23 |
Inadequate funding for rare cancers in Australia
|
Sklan, Alexandra
|
|
2014
|
15 |
12 |
p. e534-
1 p.
|
artikel
|
| 24 |
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
|
Rajkumar, S Vincent
|
|
2014
|
15 |
12 |
p. e538-e548
nvt p.
|
artikel
|
| 25 |
Intratumour heterogeneity in lung cancer
|
Yaqub, Farhat
|
|
2014
|
15 |
12 |
p. e536-
1 p.
|
artikel
|
| 26 |
Laughter is the best medicine
|
Lucas, Catherine
|
|
2014
|
15 |
12 |
p. 1300-1301
2 p.
|
artikel
|
| 27 |
Length of chemotherapy and use of bevacizumab for breast cancer
|
Brufsky, Adam
|
|
2014
|
15 |
12 |
p. 1285-1287
3 p.
|
artikel
|
| 28 |
Local treatments for metastases of renal cell carcinoma: a systematic review
|
Dabestani, Saeed
|
|
2014
|
15 |
12 |
p. e549-e561
nvt p.
|
artikel
|
| 29 |
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening
|
Horeweg, Nanda
|
|
2014
|
15 |
12 |
p. 1332-1341
10 p.
|
artikel
|
| 30 |
Lung cancer screening: achieving more by intervening less
|
Mulshine, James L
|
|
2014
|
15 |
12 |
p. 1284-1285
2 p.
|
artikel
|
| 31 |
Lung cancer screening less accurate with endemic lung disease
|
Tanday, Sanjay
|
|
2014
|
15 |
12 |
p. e529-
1 p.
|
artikel
|
| 32 |
Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial
|
Gligorov, Joseph
|
|
2014
|
15 |
12 |
p. 1351-1360
10 p.
|
artikel
|
| 33 |
Maintenance pazopanib in ovarian cancer
|
Rahman, Ahmadur
|
|
2014
|
15 |
12 |
p. e530-
1 p.
|
artikel
|
| 34 |
New therapeutic target for non-small-cell lung cancer
|
Sharma, Sharan Prakash
|
|
2014
|
15 |
12 |
p. e533-
1 p.
|
artikel
|
| 35 |
NHS privatisation: a step too far
|
Crawford, S Michael
|
|
2014
|
15 |
12 |
p. e527-
1 p.
|
artikel
|
| 36 |
Pan-HER inhibition in EGFR wild-type non-small-cell lung cancer
|
Peters, Solange
|
|
2014
|
15 |
12 |
p. 1289-1290
2 p.
|
artikel
|
| 37 |
Prediction model for heart failure in childhood cancer survivors
|
Rahman, Ahmadur
|
|
2014
|
15 |
12 |
p. e537-
1 p.
|
artikel
|
| 38 |
Provision for cancer patients a priority in primary care reforms
|
The Lancet Oncology,
|
|
2014
|
15 |
12 |
p. 1279-
1 p.
|
artikel
|
| 39 |
Quality of life with treated acute promyelocytic leukaemia
|
Rahman, Ahmadur
|
|
2014
|
15 |
12 |
p. e533-
1 p.
|
artikel
|
| 40 |
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
|
Donker, Mila
|
|
2014
|
15 |
12 |
p. 1303-1310
8 p.
|
artikel
|
| 41 |
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
|
Fowler, Nathan H
|
|
2014
|
15 |
12 |
p. 1311-1318
8 p.
|
artikel
|
| 42 |
Surgery or topical therapy for vulval intraepithelial neoplasia
|
Mahner, Sven
|
|
2014
|
15 |
12 |
p. 1287-1288
2 p.
|
artikel
|
| 43 |
T-cell therapy for paediatric acute lymphoblastic leukaemia
|
Lokody, Isabel
|
|
2014
|
15 |
12 |
p. e536-
1 p.
|
artikel
|
| 44 |
Testing urine for cervical human papillomavirus
|
Yaqub, Farhat
|
|
2014
|
15 |
12 |
p. e531-
1 p.
|
artikel
|
| 45 |
56th ASTRO annual meeting
|
Brierley, Rob
|
|
2014
|
15 |
12 |
p. 1296-
1 p.
|
artikel
|
| 46 |
The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support
|
Warren, Graham W
|
|
2014
|
15 |
12 |
p. e568-e580
nvt p.
|
artikel
|
| 47 |
Thoracoscopic lobectomy versus thoracotomy for NSCLC
|
Yaqub, Farhat
|
|
2014
|
15 |
12 |
p. e535-
1 p.
|
artikel
|
| 48 |
Toms River
|
Dolan, Nicolas
|
|
2014
|
15 |
12 |
p. 1301-1302
2 p.
|
artikel
|
| 49 |
Towards a chemotherapy-free approach in indolent lymphoma
|
Buske, Christian
|
|
2014
|
15 |
12 |
p. 1281-1282
2 p.
|
artikel
|
| 50 |
UK Early Access to Medicines Scheme
|
Burki, Talha Khan
|
|
2014
|
15 |
12 |
p. e531-
1 p.
|
artikel
|
| 51 |
Uncaria tomentosa, the cat's whiskers or claws?
|
Froeling, Fieke E M
|
|
2014
|
15 |
12 |
p. 1299-1300
2 p.
|
artikel
|
| 52 |
US legislation has little effect on chemotherapy prescribing
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
12 |
p. e532-
1 p.
|
artikel
|
| 53 |
Vemurafenib and cobimetinib in BRAF-mutated melanoma
|
Rahman, Ahmadur
|
|
2014
|
15 |
12 |
p. e535-
1 p.
|
artikel
|
Tijdschrift beschrijving